Aytu BioPharma - AYTU Net earnings per one share for the last twelve months

Aytu BioPharma Inc (AYTU) - corporate logo

Stable operations of contract manufacturing facilities minimize technical disruptions, while strict FDA oversight and patent protection create significant barriers to entry for competitors. The 12-month YoY EPS trend clearly demonstrates profit dynamics, where 27.40 characterizes this valuation parameter. Growth for Aytu BioPharma, Inc. (AYTU) relies on increasing sales of ADHD medications and the optimization of the company's debt obligations.

AYTU: Aytu BioPharma Net earnings per share for the last 12 months 02/11/2024 - 11/17/2026

Aytu BioPharma - analytical breakdowns and key metrics (AYTU)

Fundamental company valuation:AYTU - Aytu Therapeutics
Brand item of aytubio.com

Defensive assets are selected based on the criterion of stable net income growth, which is critical for Aytu BioPharma (AYTU) as it transitions to the high-margin pediatric segment and divests from loss-making brands. The annual percentage change in EPS TTM captures the actual growth rate of earnings per share over 12 months, allowing investors to assess the effectiveness of the operational pivot and the risks of a credit rating revision.

Competitor analysis

Earnings per one share for the last 12 months VRTX|ALNY: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Insmed Inc (INSM)|UTHR (United Therapeutics Corporation) - Net earnings per share (EPS TTM)|Earnings per share for the last 12 months BMRN (BioMarin)|Net earnings per share for the last 12 months BBIO (BridgeBio)|BGM: Earnings per one share for the last 12 months|Earnings per share for the last twelve months Cogent Biosciences, Inc. COGT|XERS (Xeris Biopharma Inc) - Earnings per one share for the last 12 months|Keros Therapeutics - Net earnings per share (EPS TTM)|Earnings per share for the trailing year ARCT (Arcturus Therapeutics)|ETON: Net earnings per share (EPS TTM)|Kamada Ltd (KMDA) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months Fulcrum Tx|ABEO: Earnings per share for the trailing year|Earnings per share for the last twelve months Mereo BioPharma Group (MREO)|Net earnings per share (EPS TTM) protalix.com (PLX)|Net earnings per share (EPS TTM) PLRX (Pliant Therapeutics Inc)|Net earnings per share (EPS TTM) Applied Therapeutics APLT|RNTX - Earnings per share for the last twelve months|Net earnings per share for the trailing year gelteq.com (GELS)|CMMB: Net earnings per share (EPS TTM)|SRx Health Solutions Inc. - Earnings per share for the trailing year|Earnings per share for the last twelve months Polyrizon Ltd|AEZS (Aeterna Zentaris) - Earnings per share for the last four quarters|Earnings per share for the last twelve months CTD Holdings (CYTH)|INZY: Earnings per one share for the last 12 months|Earnings per share for the last twelve months Reneo Pharmaceuticals Inc. RPHM|Net earnings per share for the last four quarters COSCIENS Biopharma Inc. (CSCI)